LCTX

SEC source: 0001493152-22-009000 · ownership.xml · nonDerivative · entry 3

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,787

F4 · price: The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.52 to not more than $1.54. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

F2 · balance_after: Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this report or shares that may be acquired upon the exercise of stock options outstanding as of the date of this report.

SEC source: 0001493152-22-009000 · ownership.xml · nonDerivative · entry 2

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,387

F3 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.

F2 · balance_after: Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this report or shares that may be acquired upon the exercise of stock options outstanding as of the date of this report.

SEC source: 0001493152-22-009000 · ownership.xml · nonDerivative · entry 1

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,730

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units ("RSUs") granted to the reporting person on September 17, 2018. RSUs convert into common shares on a one-for-one basis.

F1 · price: Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units ("RSUs") granted to the reporting person on September 17, 2018. RSUs convert into common shares on a one-for-one basis.

F2 · balance_after: Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this report or shares that may be acquired upon the exercise of stock options outstanding as of the date of this report.

SEC source: 0001493152-22-008029 · ownership.xml · nonDerivative · entry 1

Amin Dipti · CIK 0001856708 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

F1 · price: The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.48 to not more than $1.66. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

SEC source: 0000919574-22-002418 · ownership.xml · nonDerivative · entry 6

BROADWOOD PARTNERS, L.P. · CIK 0001278386 · Director · 10% owner

BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner

BRADSHER NEAL C · CIK 0001278388 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 34,935,485

F1 · ownership.nature: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0000919574-22-002418 · ownership.xml · nonDerivative · entry 5

BROADWOOD PARTNERS, L.P. · CIK 0001278386 · Director · 10% owner

BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner

BRADSHER NEAL C · CIK 0001278388 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,935,485

F4 · price: This constitutes the weighted average purchase price. The prices range from $1.36 to $1.50. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

F1 · ownership.direct: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001493152-22-007925 · ownership.xml · nonDerivative · entry 1

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,280

F1 · price: The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.3795 to not more than $1.3800. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

SEC source: 0000919574-22-002418 · ownership.xml · nonDerivative · entry 4

BROADWOOD PARTNERS, L.P. · CIK 0001278386 · Director · 10% owner

BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner

BRADSHER NEAL C · CIK 0001278388 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 34,465,485

F1 · ownership.nature: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0000919574-22-002418 · ownership.xml · nonDerivative · entry 3

BROADWOOD PARTNERS, L.P. · CIK 0001278386 · Director · 10% owner

BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner

BRADSHER NEAL C · CIK 0001278388 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,465,485

F3 · price: This constitutes the weighted average purchase price. The prices range from $1.37 to $1.44. The Reporting Person will provide upon request by the SEC Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

F1 · ownership.direct: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001493152-22-007754 · ownership.xml · nonDerivative · entry 1

Mulroy Michael H. · CIK 0001509725 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 258,555

F1 · price: The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.40 to not more than $1.41. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

SEC source: 0000919574-22-002418 · ownership.xml · nonDerivative · entry 2

BROADWOOD PARTNERS, L.P. · CIK 0001278386 · Director · 10% owner

BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner

BRADSHER NEAL C · CIK 0001278388 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 34,265,485

F1 · ownership.nature: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0000919574-22-002418 · ownership.xml · nonDerivative · entry 1

BROADWOOD PARTNERS, L.P. · CIK 0001278386 · Director · 10% owner

BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner

BRADSHER NEAL C · CIK 0001278388 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,265,485

F2 · price: This constitutes the weighted average purchase price. The prices range from $1.33 to $1.38. The Reporting Person will provide upon request by the Securities and Exchange Commission staff (the "SEC Staff"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

F1 · ownership.direct: The reported securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001493152-22-006699 · ownership.xml · derivative · entry 2

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Shares · 300,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Grant of restricted stock units under Lineage's 2021 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one Common Share.

F3 · derivative.exercise_date: One-third of the shares will vest on or prior to March 9, 2023, and the second and third anniversaries of such date, upon the achievement of certain per share performance targets, calculated based on the trailing 20 trading day volume weighted average price of the Company's common stock as of the date of determination.

F3 · derivative.expiration_date: One-third of the shares will vest on or prior to March 9, 2023, and the second and third anniversaries of such date, upon the achievement of certain per share performance targets, calculated based on the trailing 20 trading day volume weighted average price of the Company's common stock as of the date of determination.

SEC source: 0001493152-22-006699 · ownership.xml · derivative · entry 1

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250,000

Underlying: Common Shares · 1,250,000 shares

Expires 2032-03-10

F1 · derivative.exercise_date: One quarter of the options shall vest on March 10, 2023, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.

SEC source: 0001493152-22-006698 · ownership.xml · derivative · entry 1

Samuel George A. III · CIK 0001878732 · General Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 650,000

Underlying: Common Shares · 650,000 shares

Expires 2032-03-10

F1 · derivative.exercise_date: One quarter of the options shall vest on March 10, 2023, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.

SEC source: 0001493152-22-006696 · ownership.xml · derivative · entry 1

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Shares · 450,000 shares

Expires 2032-03-10

F1 · derivative.exercise_date: One quarter of the options shall vest on March 10, 2023, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.

SEC source: 0001493152-22-006694 · ownership.xml · derivative · entry 1

Cook Kevin Leon · CIK 0001870539 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 650,000

Underlying: Common Shares · 650,000 shares

Expires 2032-03-10

F1 · derivative.exercise_date: One quarter of the options shall vest on March 10, 2023, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.

SEC source: 0001493152-22-004720 · ownership.xml · derivative · entry 1

Samuel George A. III · CIK 0001878732 · General Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,303

Underlying: Common Shares · 24,303 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of restricted stock units under Lineage's 2021 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one Common Share.

F2 · derivative.exercise_date: Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023.

F2 · derivative.expiration_date: Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023.

SEC source: 0001493152-22-004718 · ownership.xml · derivative · entry 1

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,081

Underlying: Common Shares · 52,081 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of restricted stock units under Lineage's 2021 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one Common Share.

F2 · derivative.exercise_date: Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023.

F2 · derivative.expiration_date: Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023.

SEC source: 0001493152-22-004716 · ownership.xml · derivative · entry 1

Cook Kevin Leon · CIK 0001870539 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,888

Underlying: Common Shares · 13,888 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of restricted stock units under Lineage's 2021 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one Common Share.

F2 · derivative.exercise_date: Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023.

F2 · derivative.expiration_date: Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023.

SEC source: 0001493152-22-004714 · ownership.xml · derivative · entry 1

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,997

Underlying: Common Shares · 124,997 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of restricted stock units under Lineage's 2021 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one Common Share.

F2 · derivative.exercise_date: Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023.

F2 · derivative.expiration_date: Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023.

SEC source: 0001493152-22-000116 · ownership.xml · derivative · entry 3

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,900

Underlying: Common Shares · 15,450 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter.

F4 · derivative.expiration_date: The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter.

SEC source: 0001493152-22-000116 · ownership.xml · nonDerivative · entry 2

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,030

F3 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 15,450 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.

F2 · balance_after: Does not include common shares of the issuer that may be acquired upon settlement of RSUs that have not vested as of the date of this filing or upon the exercise of stock options outstanding as of the date of this filing.

SEC source: 0001493152-22-000116 · ownership.xml · nonDerivative · entry 1

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,373

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units ("RSUs") granted to the reporting person on September 17, 2018. Upon settlement, RSUs convert into common shares of the issuer on a one-for-one basis.

F1 · price: Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units ("RSUs") granted to the reporting person on September 17, 2018. Upon settlement, RSUs convert into common shares of the issuer on a one-for-one basis.

F2 · balance_after: Does not include common shares of the issuer that may be acquired upon settlement of RSUs that have not vested as of the date of this filing or upon the exercise of stock options outstanding as of the date of this filing.

SEC source: 0001493152-21-032897 · ownership.xml · derivative · entry 11

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 249,750

Underlying: Common Shares · 9,250 shares

Expires 2030-03-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The reporting person was granted options on March 17, 2020, with an exercise price of $0.6919 per share to purchase up to 444,000 common shares of the issuer. One quarter of the options vested and became exercisable on March 17, 2021, the first anniversary of the grant date, and the balance vests in 36 monthly installments thereafter upon completion of each month of the reporting person's continuous employment with the issuer.

SEC source: 0001493152-21-032897 · ownership.xml · nonDerivative · entry 7

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F3 · price: The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from $2.42 to not more than $2.52. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

SEC source: 0001493152-21-032897 · ownership.xml · nonDerivative · entry 6

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,445

F2 · price: The 9,250 shares sold on 12/29/21, were all sold at a transaction price of $2.49.

SEC source: 0001493152-21-032897 · ownership.xml · nonDerivative · entry 5

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001493152-21-032897 · ownership.xml · derivative · entry 10

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,811

Underlying: Common Shares · 79,689 shares

Expires 2029-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The reporting person was granted options on February 12, 2019, with an exercise price of $1.14 per share to purchase up to 112,500 common shares of the issuer. One quarter of the options vested and became exercisable on February 12, 2020, the first anniversary of the grant date, and the balance vests in 36 monthly installments thereafter upon completion of each month of the reporting person's continuous employment with the issuer.

SEC source: 0001493152-21-032897 · ownership.xml · derivative · entry 9

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,301

Underlying: Common Shares · 236,899 shares

Expires 2028-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The reporting person was granted options on February 11, 2018, with an exercise price of $2.11 per share to purchase up to 247,200 common shares of the issuer. One quarter of the options vested and became exercisable on February 11, 2019, the first anniversary of the grant date, and the balance vests in 36 monthly installments thereafter upon completion of each month of the reporting person's continuous employment with the issuer.

SEC source: 0001493152-21-032897 · ownership.xml · derivative · entry 8

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,000

Underlying: Common Shares · 185,000 shares

Expires 2030-03-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The reporting person was granted options on March 17, 2020, with an exercise price of $0.6919 per share to purchase up to 444,000 common shares of the issuer. One quarter of the options vested and became exercisable on March 17, 2021, the first anniversary of the grant date, and the balance vests in 36 monthly installments thereafter upon completion of each month of the reporting person's continuous employment with the issuer.

SEC source: 0001493152-21-032897 · ownership.xml · nonDerivative · entry 4

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,445

F1 · price: The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from $2.40 to not more than $2.53. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

SEC source: 0001493152-21-032897 · ownership.xml · nonDerivative · entry 3

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 530,033

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001493152-21-032897 · ownership.xml · nonDerivative · entry 2

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,344

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001493152-21-032897 · ownership.xml · nonDerivative · entry 1

Hogge Gary S. · CIK 0001771711 · SVP,Clinical & Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213,445

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001493152-22-004013 · ownership.xml · nonDerivative · entry 1

KINGSLEY ALFRED D · CIK 0001229339 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,455,545

F1 · price: During December 2021, Mr. Kingsley gifted a total of 14,700 common shares.

SEC source: 0001493152-21-025197 · ownership.xml · derivative · entry 3

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,350

Underlying: Common Shares · 15,450 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter.

F4 · derivative.expiration_date: The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter.

SEC source: 0001493152-21-025197 · ownership.xml · nonDerivative · entry 2

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,923

F3 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 15,450 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.

F2 · balance_after: Does not include common shares of the issuer that may be acquired upon settlement of RSUs that have not vested as of the date of this filing or upon the exercise of stock options outstanding as of the date of this filing.

SEC source: 0001493152-21-025197 · ownership.xml · nonDerivative · entry 1

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,266

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units ("RSUs") granted to the reporting person on September 17, 2018. Upon settlement, RSUs convert into common shares of the issuer on a one-for-one basis.

F1 · price: Shares earned by the reporting person as a result of the vesting of a portion of restricted stock units ("RSUs") granted to the reporting person on September 17, 2018. Upon settlement, RSUs convert into common shares of the issuer on a one-for-one basis.

F2 · balance_after: Does not include common shares of the issuer that may be acquired upon settlement of RSUs that have not vested as of the date of this filing or upon the exercise of stock options outstanding as of the date of this filing.

SEC source: 0001493152-21-021880 · ownership.xml · derivative · entry 1

Samuel George A. III · CIK 0001878732 · General Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 695,000

Underlying: Common Shares · 695,000 shares

Expires 2031-09-01

F1 · derivative.exercise_date: This option will vest as to one quarter of the shares subject to the option on September 1, 2022, and the balance will vest in 36 successive substantially equal monthly installments thereafter, subject to the reporting person's continuous employment.

SEC source: 0001493152-21-015886 · ownership.xml · derivative · entry 1

Russell Angus C. · CIK 0001534002 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2022, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-21-015892 · ownership.xml · derivative · entry 1

BAILEY DON M · CIK 0001223697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2022, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-21-015888 · ownership.xml · derivative · entry 1

Amin Dipti · CIK 0001856708 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2022, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-21-015890 · ownership.xml · derivative · entry 1

ANDREWS DEBORAH J · CIK 0001325697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2022, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-21-015884 · ownership.xml · derivative · entry 1

KINGSLEY ALFRED D · CIK 0001229339 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Shares · 80,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2022, subject to the reporting person's continuous service with the issuer.

SEC source: 0000919574-21-004361 · ownership.xml · derivative · entry 1

BRADSHER NEAL C · CIK 0001278388 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: COMMON SHARES · 50,000 shares

Expires 2031-07-01

F2 · price: These options were granted to the Reporting Person by the Issuer on July 1, 2021 as director compensation pursuant to the Issuer's 2012 Equity Incentive Plan, as amended.

F1 · derivative.exercise_date: These options will vest and become exercisable on July 1, 2022, provided, that Neal C. Bradsher (the "Reporting Person") remains a member of the board of directors of Lineage Cell Therapeutics, Inc. (the "Issuer") on that date.

SEC source: 0001493152-21-015882 · ownership.xml · derivative · entry 1

Mulroy Michael H. · CIK 0001509725 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2022, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-21-015880 · ownership.xml · derivative · entry 1

Jayasuriya Anula · CIK 0001822933 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Shares · 50,000 shares

Expires 2031-07-01

F1 · derivative.exercise_date: Will vest and become exercisable on July 1, 2022, subject to the reporting person's continuous service with the issuer.

SEC source: 0001493152-21-015778 · ownership.xml · derivative · entry 6

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,800

Underlying: Common Shares · 15,450 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter.

F7 · derivative.expiration_date: The reporting person was granted RSUs on September 17, 2018, that vested with respect to 25% of the shares subject to the award on September 17, 2019, and the balance vest in 12 equal quarterly installments at the end of each quarter thereafter.

SEC source: 0001493152-21-015778 · ownership.xml · nonDerivative · entry 4

Culley Brian M · CIK 0001310683 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,816

F5 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 15,450 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.

F1 · balance_after: Does not include restricted stock units ("RSUs") that may be settled in shares of the issuer's common stock that have not vested as of the date of this report or shares that may be acquired upon the exercise of stock options outstanding as of the date of this report.